Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Menopause. 2014 Aug;21(8):807–814. doi: 10.1097/GME.0000000000000194

Figure 2.

Figure 2

Modified Intent-to-Treat analysis of the mean daily count of (A) total subjective vasomotor symptoms and (B) moderate-to-very severe vasomotor symptoms.

Note. SGB=Stellate Ganglion Blockade. Total=mild, moderate, severe, very severe, and night sweats. Data points represent mean and standard error at each time point. Results are reflective of a mixed-effects Poisson regression model for count data. *** Treatment × Time (baseline to Months 4 to 6) Interaction p<0.001.